Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 9;16(1):192–200. doi: 10.3892/mmr.2017.6553

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Liu et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 2. — Effects of Bruton's tyrosine kinase on THS-induced pulmonary capillary permeability and morphological alterations. (A) BALF protein concentration and (B) pulmonary wet/dry weight ratio were detected from 6 rats of each group. Data are expressed as the mean ± standard deviation; **P<0.01 vs. Sham group; ^##P<0.05, ^##P<0.01 vs. THS group. (C) Morphological alterations were analyzed by hematoxylin and eosin staining, typical images of 5 rats per group are shown. Scale bar, 50 µm. BALF, bronchoalveolar lavage fluid; LFM-A13, a Bruton's tyrosine kinase inhibitor; THS, trauma-hemorrhagic shock.